Avenue Therapeutics, Inc. (ATXI)
0.385
-0.02
(-4.75%)
USD |
OTCM |
Oct 23, 16:00
Avenue Therapeutics Enterprise Value : -0.6734M for Oct. 23, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 23, 2026 | -0.6734M |
| October 22, 2026 | -0.6102M |
| October 21, 2026 | -0.6102M |
| October 20, 2026 | -0.6102M |
| October 19, 2026 | -0.5252M |
| October 16, 2026 | -0.5252M |
| October 15, 2026 | -0.5252M |
| October 14, 2026 | -0.5252M |
| October 13, 2026 | -0.5581M |
| October 12, 2026 | -0.6225M |
| October 09, 2026 | -0.5258M |
| October 08, 2026 | -0.5258M |
| October 07, 2026 | -0.4625M |
| October 06, 2026 | -0.6899M |
| October 05, 2026 | -0.6899M |
| October 02, 2026 | -0.599M |
| October 01, 2026 | -0.7558M |
| September 30, 2026 | -0.624M |
| September 29, 2026 | -0.624M |
| September 28, 2026 | -0.2945M |
| September 25, 2026 | -0.2945M |
| September 24, 2026 | -0.2945M |
| September 23, 2026 | -0.7558M |
| September 22, 2026 | -0.2945M |
| September 21, 2026 | -0.3684M |
| Date | Value |
|---|---|
| September 18, 2026 | -0.3684M |
| September 17, 2026 | -0.3684M |
| September 16, 2026 | -0.0843M |
| September 15, 2026 | 0.1503M |
| September 14, 2026 | 0.3039M |
| September 11, 2026 | 0.0351M |
| September 10, 2026 | 0.7731M |
| September 09, 2026 | 0.2057M |
| September 08, 2026 | -0.1627M |
| September 04, 2026 | -0.148M |
| September 03, 2026 | -0.0639M |
| September 02, 2026 | -0.0639M |
| September 01, 2026 | -0.2286M |
| August 31, 2026 | -0.4527M |
| August 28, 2026 | -0.4527M |
| August 27, 2026 | -0.0408M |
| August 26, 2026 | -0.4592M |
| August 25, 2026 | -0.5911M |
| August 24, 2026 | -1.093M |
| August 21, 2026 | -1.093M |
| August 20, 2026 | -1.093M |
| August 19, 2026 | -1.093M |
| August 18, 2026 | -1.093M |
| August 17, 2026 | -1.093M |
| August 14, 2026 | -1.093M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| ANI Pharmaceuticals, Inc. | 1.903B |
| Corcept Therapeutics, Inc. | 8.967B |
| Veru, Inc. | 15.08M |
| Johnson & Johnson | 662.44B |
| Eli Lilly & Co. | 1.245T |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.69M |
| Total Expenses (Quarterly) | 0.69M |
| EPS Diluted (Quarterly) | -0.2094 |
| Earnings Yield | -222.8% |
| Normalized Earnings Yield | -222.78 |